A detailed history of Td Waterhouse Canada Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 1,351 shares of CRL stock, worth $234,911. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,351
Previous 1,722 21.54%
Holding current value
$234,911
Previous $332 Million 24.91%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$178.58 - $220.69 $66,253 - $81,875
-371 Reduced 21.54%
1,351 $249 Million
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $56,575 - $73,832
301 Added 21.18%
1,722 $332 Million
Q2 2024

Nov 12, 2024

SELL
$206.39 - $268.73 $14,653 - $19,079
-71 Reduced 4.76%
1,421 $289 Million
Q1 2024

May 10, 2024

BUY
$203.52 - $273.43 $35,208 - $47,303
173 Added 13.12%
1,492 $392 Million
Q4 2023

Feb 12, 2024

SELL
$164.52 - $238.84 $1,151 - $1,671
-7 Reduced 0.53%
1,319 $296 Million
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $4,666 - $5,222
-24 Reduced 1.78%
1,326 $258 Million
Q2 2023

Nov 13, 2023

SELL
$183.71 - $210.25 $12,124 - $13,876
-66 Reduced 4.66%
1,350 $283 Million
Q1 2023

Nov 13, 2023

SELL
$191.89 - $259.92 $4,797 - $6,498
-25 Reduced 1.73%
1,416 $285 Million
Q3 2022

Nov 13, 2023

BUY
$182.44 - $250.54 $12,223 - $16,786
67 Added 4.88%
1,441 $295 Million
Q2 2022

Nov 13, 2023

BUY
$204.13 - $302.4 $1,020 - $1,512
5 Added 0.37%
1,374 $302 Million
Q1 2022

Nov 13, 2023

SELL
$255.51 - $362.11 $37,304 - $52,868
-146 Reduced 9.64%
1,369 $398 Million
Q4 2021

Nov 13, 2023

BUY
$351.38 - $448.68 $532,340 - $679,750
1,515 New
1,515 $531 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.